This readme.txt file was generated on 20190829 by Matthew Jones ------------------- GENERAL INFORMATION ------------------- 1. Impact of systematic user testing of written guidance on the rate of moderate to severe errors made by hospital nurses during in situ simulation of the preparation and administration of an intravenous medicine: phase 1 – user testing 2. Author Information Principal Investigator Contact Information Name: Dr Matthew D Jones Institution: Department of Pharmacy and Pharmacology, University of Bath Address: Department of Pharmacy and Pharmacology, University of Bath, Bath, BA2 7AY, United Kingdom. Email: M.D.Jones@bath.ac.uk Associate or Co-investigator Contact Information Name: Prof DK Theo Raynor Institution: University of Leeds and Luto Research Ltd, Leeds Address: Dawsons House, Owlcotes Lane, Pudsey, Leeds LS28 6PY, United Kingdom. Email: TRaynor@luto.co.uk Associate or Co-investigator Contact Information Name: Prof Margaret Watson Institution: University of Strathclyde Address: Strathclyde Institute Of Pharmacy And Biomedical Sciences, 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom. Email: margaret.watson@strath.ac.uk Associate or Co-investigator Contact Information Name: Prof Bryony Dean Franklin Institution: UCL School of Pharmacy Address: 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom. Email: bryony.deanfranklin@ucl.ac.uk 3. Date of data collection 20180430 to 20181017 4. Geographic location of data collection (where was data collected?): England 5. Information about funding sources that supported the collection of the data: National Institute for Health Research, Trainees Co-ordinating Centre, Leeds Innovation Centre, 103 Clarendon Road, Leeds, LS2 9DF. TRF-2017-10-006. “Matthew Jones is funded by a National Institute for Health Research (NIHR), Transitional Research Fellowship for this research project. This dataset presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.” --------------------- DATA & FILE OVERVIEW --------------------- 1. File List A. Filename: Phase_1_protocol.pdf Short description: Full research protocol describing how the data were collected and analysed. PDF format. Created 190904. -------- Packaged in Data_collection_tools.zip: B. Filename: Demographics_form.pdf Short description: Form used to collect participant demographic data. PDF format. Created 20180205. C. Filename: Interview_schedule_round_1.pdf Short description: Interview schedule used in round 1 interviews. PDF format. Created 20180504. D. Filename: Interview_schedule_rounds_2_and_3.pdf Short description: Interview schedule used in rounds 2 and 3 interviews. PDF format. Created 20180629. ------- Packaged in Interview_transcriptions.zip: E. Filename: A*_transcription.rtf (where * is participant number (28 files)) Short description: Anonymised transcriptions of user testing interviews with 28 participants. Due to unexpected work pressures on the day of their interviews, participants A10 and A20 could not take part in a full audio recorded interview. Analysis of these interviews was therefore based only on written notes. RTF format. Created 20180521 to 20191101. ------- Packaged in Thematic_analysis.zip: F. Filename: Thematic_Analysis.nvp Short description: File documenting the final thematic analysis. It shows the final coding of all interview transcriptions, as well as the final relationship between individual codes, sub-themes and themes. The file is in .nvp format created in Nvivo version 11 software. Created 20190602. G. Filename: Thematic_description.pdf Short description: Full thematic description of the semi-structured interview data analysed with thematic analysis. The file is in PDF format. Created 20190904 ------- Packaged in Numerical_data.zip: H. Filename: Phase_1_Demographics.sav Short description: File showing demographics of interview participants. The file is in .sav format created in SPSS version 25 software. Created 20181018. I. Filename: User_test_question_responses.sav Short description: File showing participants' responses to the 17 user test questions (see interview schedules for details of the questions). The file is in .sav format created in SPSS version 25 software. Created 20181018. ------- Packaged in IMG_guides.zip J. Filename: Round_1_guides.docx Short description: The injectable medicines guides tested during round 1. The file is in .docx format. Created 20190829. K. Filename: Round_2_guides.docx Short description: The injectable medicines guides tested during round 2. Changes and the reasons for them are annotated as comments. The file is in .docx format. Created 20190829. L. Filename: Round_3_guides.docx Short description: The injectable medicines guides tested during round 3. Changes and the reasons for them are annotated as comments. The file is in .docx format. Created 20190829. M. Filename: Final_guides.docx Short description: The final injectable medicines guides at the end of the project. Changes and the reasons for them are annotated as comments. The file is in .docx format. Created 20190829. 2. Relationship between files: N/A 3. Additional related data collected that was not included in the current data package: None 4. Are there multiple versions of the dataset? No -------------------------- METHODOLOGICAL INFORMATION -------------------------- 1. Description of methods used for collection/generation of data: See file Phase_1_protocol.pdf 2. Methods for processing the data: See file Phase_1_protocol.pdf 3. Instrument- or software-specific information needed to interpret the data: N/A 4. Standards and calibration information, if appropriate: N/A 5. Environmental/experimental conditions: N/A 6. Describe any quality-assurance procedures performed on the data: Interview transcriptions were double checked and corrected by a second person. Numerical data entry was double checked on a second occasion. 7. People involved with sample collection, processing, analysis and/or submission: All stages performed by Matthew Jones (details above). ----------------------------------------- DATA-SPECIFIC INFORMATION FOR: Phase_1_Demographics.sav ----------------------------------------- 1. Number of variables: 10 2. Number of cases/rows: 30 3. Variable List A. Name: ID Description: Participant ID number B. Name: Round Description: User testing round number C. Name: Interview Description: Interview number within the round of interviews D. Name: Gender Description: Participant's gender 1 = Female, 2 = Male, 3 = Self-describe, 4 = Prefer not to say E. Name: Age Description: Participant's age in years F. Name: English Description: Was English the participant's first language? 0 = no, 1 = yes G. Name: Organisation Description: NHS organisation employing the participant 1 = hospital 1, 2 = hospital 2, 3 = hospital 3. No further details are provided to prevent identification of the research sites. H. Name: NursingYears Description: The number of years the participant had been a registered nurse or midwife I. Name: IVyears Description: The number of years the participant had been authorised to administer intravenous medicines J. Name: IVpercent Description: Percentage of working shifts over the past 6 months during which the participant had administered an IV medicine. 4. Missing data codes: N/A 5. Specialized formats of other abbreviations used N/A ----------------------------------------- DATA-SPECIFIC INFORMATION FOR: User_test_question_responses.sav ----------------------------------------- 1. Number of variables: 72 2. Number of cases/rows: 30 3. Variable List A. Name: ID Description: Participant ID number B. Name: Round Description: User testing round number C. Name: Interview Description: Interview number within the round of interviews D. Name: FirstMono Description: The injectable medicines guide tested first in the interview 1 = bathicillin, 2 = unimycin E. Name: Find2.* (where * is the user testing question number (see interview schedules). 17 variables like this in total) Description: Whether the participant could find the information required to answer the relevant user testing question. 1 = not found, 2 = found with difficulty, 3 = found F. Name: Exp2.* (where * is the user testing question number (see interview schedules). 17 variables like this in total) Description: Whether the participant could explain the information required to answer the relevant user testing question. 1 = not understood, 2 = not applicable, 3 = understood G. Name: Prompt2.* (where * is the user testing question number (see interview schedules). 17 variables like this in total) Description: The number of prompts required to answer the relevant user testing question. H. Name: Time2.* (where * is the user testing question number (see interview schedules). 17 variables like this in total) Description: The number of seconds taken to answer the relevant user testing question. 4. Missing data codes: N/A 5. Specialized formats of other abbreviations used N/A